Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AA, accredited, advocacy, Alynylam, amenable, ASN, assign, assignment, back, bioavailable, booster, budesonide, campaign, cardiology, cessation, climate, confirmatory, Cundari, CV, Delta, diastolic, disclaimer, disproportionate, Dominic, Edgewise, Elijah, endothelial, entirety, environmental, ESG, expedite, facility, Fast, faster, fatal, Franchise, FTC, Genentech, geometric, guard, Head, ID, Idera, inclusive, inflammatory, influential, ingredient, Iowa, irritation, ISO, Kirsten, leave, lengthened, Master, media, Michigan, Microbiology, mmHg, modality, molecule, multinational, musculoskeletal, NEFECON, Nephrology, neurologist, neuromuscular, occlusion, Omicron, orally, preliminary, prioritized, Psychology, PTO, reclassified, remitted, resurgence, Roche, RSA, RSU, Russia, SAR, shaping, shift, slightly, social, specialist, spectrum, stable, stakeholder, SUNY, surge, sympton, systolic, TARPEYO, telemedicine, thrombolytic, Track, Ukraine, undertaken, uninsured, UPCR, Upstate, vaccine, variant, verification, Villanova, Wave
Removed:
analyzing, ascending, AUD, bridging, broad, Chinese, delisted, deny, disrupt, diversified, DMA, DMCAD, DMCAF, emergent, exclusively, exhibited, glycogen, halt, ineligible, inhibit, instituted, interpret, investigated, justified, mimicked, Mine, notable, organic, OTCQB, pain, precluding, presence, proper, protective, qualitative, quantitative, reconcile, refundable, rejecting, remedy, restrictive, route, sample, scar, Scientist, select, sensitization, sheet, sued, Supplementary, suspending, terminating, tolerance, TSX, undermined, unsuccessful, upregulate, uptake, voluntarily, withdrawing
Filing tables
Filing exhibits
Related press release
Associated DMAC transcripts
DMAC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-235775, 333-260066 and 333-254089) and Form S-8 (File Nos. 333-228821 and 333-231717) of DiaMedica Therapeutics Inc. of our report dated March 14, 2022, relating to the consolidated financial statements of DiaMedica Therapeutics Inc., which appears in this annual report on Form 10-K for the fiscal year ended December 31, 2021.
/s/ Baker Tilly US, LLP
Minneapolis, Minnesota
March 14, 2022